81. Congenital adrenal hyperplasia Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 87 / Drugs : 87 - (DrugBank : 23) / Drug target genes : 12 - Drug target pathways : 68
Congenital adrenal hyperplasia and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 81 | Congenital adrenal hyperplasia | - |
| 86 | Pulmonary arterial hypertension | 10.184 |
| 13 | Multiple sclerosis/Neuromyelitis optica | 8.396 |
| 6 | Parkinson disease | 6.858 |
| 67 | Polycystic kidney disease | 5.895 |
| 97 | Ulcerative colitis | 5.483 |
| 96 | Crohn disease | 4.205 |
| 50 | Dermatomyositis | 3.375 |
| 193 | Prader-Willi syndrome | 3.353 |
| 298 | Hereditary pancreatitis | 3.340 |
| 113 | Muscular dystrophy | 3.305 |
| 75 | Cushing disease | 3.290 |
| 49 | Systemic lupus erythematosus | 3.158 |
| 2 | Amyotrophic lateral sclerosis | 3.105 |
| 46 | Malignant rheumatoid arthritis | 3.097 |
| 78 | Hypopituitarism | 2.415 |
| 167 | Marfan syndrome | 2.400 |
| 58 | Hypertrophic cardiomyopathy | 2.387 |
| 90 | Retinitis pigmentosa | 2.381 |
| 226 | Interstitial cystitis with Hunners ulcer | 2.311 |
| 70 | Spinal stenosis | 2.304 |
| 65 | Primary immunodeficiency | 2.245 |
| 51 | Scleroderma | 2.212 |
| 77 | Growth hormone secreting pituitary adenoma | 2.000 |
| 83 | Addison disease | 1.875 |
| 265 | Lipodystrophy | 1.744 |
| 272 | Fibrodysplasia ossificans progressiva | 1.744 |
| 285 | Fanconi anemia | 1.689 |
| 60 | Aplastic anemia | 1.587 |
| 140 | Dorabe syndrome | 1.556 |
| 144 | Lennox-Gastaut syndrome | 1.551 |
| 222 | Primary nephrotic syndrome | 1.508 |
| 156 | Rett syndrome | 1.472 |
| 299 | Cystic fibrosis | 1.444 |
| 211 | Hypoplastic left heart syndrome | 1.000 |
| 220 | Rapidly progressive glomerulonephritis | 1.000 |
| 30 | Distal myopathy | 1.000 |